Hear a transfemme nonbinary individual living with HIV—in conversation with her infectious diseases physician, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS—share her experience navigating the healthcare system, including barriers faced and opportunities for healthcare professionals to improve care for gender-diverse people.

Learn from Rebekah Fenton, MD, MPH, and Sharon G. Humiston, MD, MPH, about strategies to achieve health equity in HPV vaccination and cancer prevention in patients from diverse populations. In addition, hear them answer frequently asked questions.

Hear from Meredith E. Clement, MD, and Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD, as they discuss their insights on some of the most clinically relevant new data presented at HIVR4P 2024, covering studies on investigational PrEP options and strategies to improve PrEP implementation and uptake.

Listen to Rebekah Fenton, MD, MPH, and Sharon G. Humiston, MD, MPH discuss strategies to improve your messaging techniques with patients and their families about the HPV vaccine to improve uptake and prevent certain types of cancer.

Listen in as Sharon G. Humiston, MD, MPH, discusses HPV burden, including incidence of HPV-attributable cancer cases, and how HPV vaccination can prevent certain types of cancers.

Listen as Kathleen Page, MD, and Glenn J. Treisman, MD, PhD, discuss approaches to reframing the conversation about addiction and overcoming barriers to effective addiction care for people living with HIV.

Listen to Alexander Wong, MD, FRCPC, share his experience caring for people with HIV with substance use disorders, including personal successes within his clinic in overcoming barriers to care by collaborating in a multidisciplinary team, providing colocated services, implementing opioid agonist therapy, and understanding cultural dynamics.

Listen as Jennifer Cocohoba, PharmD, AAHIVP, and David Koren, PharmD, MPH, AAHIVP, FIDSA, discuss exciting new data on HIV care and prevention—specifically LA ART and LA PrEP—from AIDS 2024 and learn how to integrate these data into your practice to optimize HIV prevention and treatment.

Listen as Tristan J. Barber, MA, MD, FRCP, and Glenn J. Treisman, MD, PhD, discuss the intersectionality of PTSD, trauma, and HIV. Learn their strategies to make PTSD and trauma care an integral part of HIV care, including methods to improve screening for, diagnosing, and treating PTSD in people with HIV.

Listen as Colleen F. Kelley, MD, MPH, and patient advocate, Jemma , discuss ways to improve access to HIV care for transgender persons with HIV, provide integrated care with colocated services for HIV and gender-affirming care, and deliver person-centered care.

Listen as Drs Aadia Rana and Laurence Slama discuss the subtleties of deciding among HIV treatment options in people with adherence challenges. They explore resistance considerations, recommendations concerning proviral DNA genotyping, and how to interpret guidelines for long-acting ART in this population, including its potential risks and benefits.

Listen as Gregory Huhn, MD, MPHTM, discusses a case study of a person with HIV and multiclass resistance, exploring when and how to consider agents with novel mechanisms of action.

Using a case study, Prof Yvonne Gilleece discusses why she believes giving people space and time to engage in HIV care on their terms is key to overcoming potential barriers to care.

In episode 4 of this series, a patient with chronic hepatitis B (CHB) shares with his hepatologist, Professor George Lau, his challenges with HBV care. Listen as they discuss barriers in adhering to antiviral therapy and in managing the diagnosis of hepatocellular carcinoma.

Listen as Gregory Huhn, MD, discusses how important it is to carefully re-examine treatment choices with people with HIV, always asking them if they are on the best regimen for their needs.

Listen as Lucas Hill, PharmD, AAHIVP, BCACP, and Bernadette Jakeman, PharmD, PhC, BCPS, AAHIVP, discuss what pharmacists need to know to provide high-quality HIV care beyond viral suppression, including treatment strategies and tips for addressing and improving patients’ quality of life.

Listen as a panel of experts—including 2 hepatologists and a person living with primary biliary cholangitis (PBC)—discuss ways to optimize pruritus care in the clinic, including the importance of asking patients about pruritus and clinical pearls about PBC pruritus treatment options.

Listen as a panel of experts—including 2 hepatologists and a person living with primary biliary cholangitis (PBC)—discuss the patient experience with cholestatic pruritus in PBC: how people describe the impact of cholestatic pruritus, the extent to which pruritus negatively affects quality of life, and the importance of educating healthcare professionals on this important symptom of PBC.

Listen as 2 experts discuss the intersectionality of depression and HIV and strategies to make depression care an integral part of HIV care, including methods to improve screening for, diagnosing, and treating depression in people living with HIV.

Listen as Drs Cristina Mussini and William Short discuss the potential role of antiretroviral therapy (ART) in weight change among people living with HIV, whether ART switch can lead to weight loss after weight gain, and how to counsel people living with HIV on weight loss options, including lifestyle modifications and nonpharmacologic methods.

Using a case study, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, illustrates why patients living with HIV may disengage with their care, especially when unexpected barriers present. Learn why the return to care should be celebrated, how to support people living with HIV as they reengage in care, and how to prevent future loss to follow-up.

In this second podcast of our series, hear expert faculty Carlos del Rio, MD, and Aniruddha Hazra, MD, explore the CDC recommendations for mpox protection and discuss how vaccination can lead to immunologic equity.

Hear expert faculty Carlos del Rio, MD, and Aniruddha Hazra, MD, discuss answers to common questions about the risk, impact, and recommendations for protection against mpox.

Listen as Roger Bedimo, MD, MS, FACP, examines patient and regimen-based PrEP barriers and discusses practical interventions to support PrEP adherence in key populations.